Antiarrhythmic drugs-clinical use and clinical decision making: A consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)

Gheorghe Andrei Dan, Antoni Martinez-Rubio, Stefan Agewall, Giuseppe Boriani, Martin Borggrefe, Fiorenzo Gaita, Isabelle Van Gelder, Bulent Gorenek, Juan Carlos Kaski, Keld Kjeldsen, Gregory Y.H. Lip, Bela Merkely, Ken Okumura, Jonathan P. Piccini, Tatjana Potpara, Birgitte Klindt Poulsen, Magdi Saba, Irina Savelieva, Juan L. Tamargo, Christian WolpertChristian Sticherling, Joachim R. Ehrlich, Richard Schilling, Nikola Pavlovic, Tom De Potter, Andrzej Lubinski, Jesper Hastrup Svendsen, Keong Ching, John Lewis Sapp, Carol Chen-Scarabelli, Felipe Martinez

    Research output: Contribution to journalReview articleResearchpeer-review

    34 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)731-732
    JournalEuropace
    Volume20
    Issue number5
    DOIs
    Publication statusPublished - 1 May 2018

    Keywords

    • Antiarrhythmic drugs
    • Arrhythmias
    • Atrial fibrillation
    • Bradycardia
    • EHRA consensus document
    • Extrasystoles
    • Pre-excitation
    • Proarrhythmias
    • Sudden cardiac death
    • Supraventricular arrhythmias
    • Ventricular tachycardia

    Cite this